Seasoned finance executive focused on private equity and growth-stage investing with operational and board experience across technology and industrial sectors. Gregory A. Brown has held senior roles driving deal sourcing, portfolio operations and capital formation, and is known for strategic carve-outs and operational turnarounds. Market-oriented, speaks to LP relations, capital strategy, and value-creation plans for mid-market companies.
Seasoned finance executive focused on private equity and growth-stage investing with operational and board experience across technology and industrial sectors. Gregory A. Brown has held senior roles driving deal sourcing, portfolio operations and capital formation, and is known for strategic carve-outs and operational turnarounds. Market-oriented, speaks to LP relations, capital strategy, and value-creation plans for mid-market companies.
Targets mid-market private equity and growth-stage opportunities with an operationally driven, value‑creation approach. Prefers technology and industrial plays where carve-outs, strategic restructuring and hands‑on portfolio operations can accelerate EBITDA growth. Employs disciplined capital allocation blending control investments and minority growth rounds, focuses on operational KPIs, margin expansion and cash-flow improvement. Investment horizon is medium-term (3–7 years) with active board involvement, rigorous downside protection and exit planning tied to strategic buyers or growth IPOs.
Targets mid-market private equity and growth-stage opportunities with an operationally driven, value‑creation approach. Prefers technology and industrial plays where carve-outs, strategic restructuring and hands‑on portfolio operations can accelerate EBITDA growth. Employs disciplined capital allocation blending control investments and minority growth rounds, focuses on operational KPIs, margin expansion and cash-flow improvement. Investment horizon is medium-term (3–7 years) with active board involvement, rigorous downside protection and exit planning tied to strategic buyers or growth IPOs.
| Trades 1448 | Longs Won 976/1448 67% | Profit Factor 6.28 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $189,334.63 |
| Average Win $75,645.6 | Best Trade (Aug 28) $2.79M | Sharpe Ratio -241.67 |
| Average Loss -$24,923.18 | Worst Trade (Jun 29) -$436,000 | Z-Score 1.81 (92.93%) |
| Commissions $0 | Avg. Trade Length 10m 2w 1d | Expectancy $42,863.51 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 11,765 | 10,588 | 9,412 | 8,235 | 7,059 | 5,882 | 4,706 | 3,529 | 2,353 | 1,176 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAL American Airlines Group Inc. | 13,669 | $246,999 | $189,178.96 | - | -$57,820.04 | -23.41% | -0.789% |
AAPL Apple Inc. | 20,104 | $4.27M | $6.3M | - | $2.03M | 47.51% | +1.146% |
ABBV AbbVie Inc. | 2,070 | $358,180.76 | $550,185.32 | - | $192,004.56 | 53.61% | 0.0 |
ABT Abbott Laboratories | 12,572 | $1.36M | $1.43M | - | $75,737.1 | 5.57% | -1.748% |
AEP American Electric Power Company, Inc. | 3,801 | $427,612.94 | $466,648.77 | - | $39,035.83 | 9.13% | 0.0 |
AER AerCap Holdings N.V. | 1,971 | $270,381.58 | $295,314.93 | - | $24,933.35 | 9.22% | +1.621% |
AGCO AGCO Corporation | 1,893 | $219,468.1 | $210,009.42 | - | -$9,458.68 | -4.31% | 0.0 |
AGGH Simplify Aggregate Bond ETF | 26,857 | $541,706 | $536,602.86 | - | -$5,103.14 | -0.94% | 0.0 |
AIS VistaShares Artificial Intelligence Supercycle ETF | 4,268 | $364,103 | $364,103 | - | - | - | 0.0 |
ALAB ASTERA LABS INC COMMON STOCK (Ticker: 1ALAB) | 450 | $217,359 | $127,192.5 | - | -$90,166.5 | -41.48% | 0.0 |
ALL Allstate Corporation | 2,243 | $454,919.39 | $577,841.66 | - | $122,922.27 | 27.02% | 0.0 |
AMCR Amcor plc | 6,287 | $250,761.93 | $296,432.05 | - | $45,670.12 | 18.21% | -0.254% |
AMG Affiliated Managers Group Inc. | 608 | $168,233.8 | $222,090.24 | - | $53,856.44 | 32.01% | 0.0 |
AMGN Amgen Inc. | 1,328 | $395,301.16 | $587,294.71 | - | $191,993.55 | 48.57% | 0.0 |
AMZN Amazon.com Inc | 26,802 | $5.23M | $7M | - | $1.76M | 33.72% | 0.0 |
APH Amphenol Corporation | 20,772 | $823,600.88 | $3.3M | - | $2.47M | 300.46% | 0.0 |
ARE Alexandria Real Estate Equities, Inc. | 8,797 | $431,061.11 | $465,361.3 | - | $34,300.19 | 7.96% | 0.0 |
ASB Associated Banc-Corp | 6,674 | $184,135.66 | $205,692.68 | - | $21,557.02 | 11.71% | 0.0 |
ASML ASML Holding N.V. New York Registry Shares | 501 | $560,845.76 | $873,824.16 | - | $312,978.4 | 55.8% | 0.0 |
AVDE Avantis International Equity ETF | 72,728 | $4.67M | $6.89M | - | $2.22M | 47.54% | 0.0 |